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A B S T R A C T
The aim of this study was to evaluate the quality of pain management in hospitalised patients. A cross-sectional study
design that included all medical patients experiencing pain was used. Out of 167 patients hospitalized at the Department
of Medicine at the University Hospital Zagreb, 41 patients were experiencing pain and 40 out of them received analgesics.
Twenty-two out of 38 patients were treated for malignant pain, 16 for non-malignant pain, and 2 patients could not be
classified. Adequate pain relief was reported in less than 25% of patients in both groups. Our study revealed under-pre-
scribing of combination therapy, low utilization rates of strong opioids and prevailing »as needed« prescribing practice.
In conclusion, unsatisfactory pain management in medical patients is often present if left solely to the clinical judgement
and knowledge of the prescribing physician. Regular pain assessment, evidence-based guidelines, education and regular
audits of implementation of these measures are a prerequisite for effective pain treatment, and should all be employed in
patients experiencing pain.
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Introduction
Pain accompanying malignant or chronic non-malig-
nant disease should be considered unnecessary. Uncon-
trolled pain compromises patients’ physiological as well
as psychological functioning, and substantially lowers
their quality of life1,2. The overall social and economic ef-
fects of uncontrolled pain are not easy to evaluate in
terms of delayed healing, prolonged recovery and length
of stay, yet some studies have shown that adequate pain
control is cost-effective3,4, and leads to reduction of mor-
bidity and improvement in clinical outcomes5–9. The exis-
tence of unnecessary pain is common in research reports
on pain management in hospital patients, as well as
among outpatients. It has been reported that about three-
-quarters of patients experience moderate to severe pain
while in hospital10–12. Barriers to satisfactory pain man-
agement include nurses’ and physicians’ insufficient know-
ledge and education about pain assessment and treat-
ment13–16, organizational issues17 as well as concerns
about the risk of addiction to opioids18. Evidence-based
guidelines and education are recognized tools for im-
provement of pain management19,20.
There is a wide range of medications available to the
physician in pain treatment. To help in rational clinical
decision-making, the World Health Organization has es-
tablished therapeutic guidelines in the pharmacologic
treatment of pain21. Adherence to this simple guideline
with appropriate dosing of drugs can provide adequate
pain relief in 70–90% of patients22. The concern of many
physicians and patients about addiction to opoids is a
major obstacle to adequate pain relief, although it has
been suggested that less than 1 in 1000 patients using
opioids for pain relief would be expected to develop an
addiction23. A recent review by Hojsted J and Sjogren P24
suggests that it seems appropriate to be aware of the
problems associated with addiction during long-term
opioid treatment, since the review of literature indicate
that the prevalence of addiction varies from 0–50% in
chronic non-malignant pain patients, and from 0–7.7% in
cancer patients25. Nevertheless, it should not be the ex-
cuse for undertreatment of pain.
Most published studies tackle management strategies
of departments dealing with patients in pain (Surgery,
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Oncology, Emergency Department, Neurology), often dis-
regarding other subgroups of patients. We assessed cur-
rent practices of pain management and satisfaction with
pain relief in medical patients, whose pain management
was left to the clinical judgment and knowledge of the pre-
scribing physician. Since this was the first study dealing
with pain management strategies in our hospital, no cohe-
rent previous information on pain relief and patient satis-
faction was available. At the time of this study there were
no local guidelines for pain treatment in our institution.
Materials and Methods
Study design and patient population
A group of six clinical pharmacologists conducted a
cross-sectional study that included all patients hospital-
ized at the Department of Medicine at the University
Hospital Zagreb receiving analgesics on the day of the
study (February 25th, 2005). A structured questionnaire
was developed based on the American Pain Society pa-
tient outcome questionnaire26. Data were collected by pa-
tient interview and from hospital charts and medical his-
tories. Patients’ experience of pain was assessed on a
numeric rating scale (NRS) ranging from 1 to 10. Pa-
tients indicated their experience of pain on NRS; 0 mean-
ing the absolute absence of pain, and 10 meaning disa-
bilitating pain. According to literature data27 and in
agreement with patients, we set the threshold indicating
inadequate pain control for worst pain at 5 (moderate
pain), and the threshold for average pain at 3 (mild pain).
The threshold for most severe pain was set at 7. The aims
of the study were explained, and an informed oral con-
sent was obtained from all patients prior to inclusion.
Since this was an observational study, the ethical ap-
proval was not considered necessary.
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TABLE 1
DEMOGRAPHICS AND TYPE OF PAIN
Malignant pain Non-malignant pain p-value
Mean SD Mean SD
Age 55 17 58 16 n.s.*
N % N %
Sex n.s.
Male 11 50 8 50
Female 11 50 8 50
Type of pain
Acute 4 18 8 50 0,037
Chronic 18 82 8 50
Continuous 13 59 7 44 n.s.
Periodical 9 41 9 56
Diagnosis
Acute leucosis 3 Headache 3
Ca ventriculi 3 Abdominal pain 3
Seminoma 2 Pancreatitis 2
Plasmocytoma 2 Chest pain 2
Ca pulmonum 2 Arthritis 1
Osteosarcoma 1 Collagenosis 1
Meta ossei 1 Mucositis 1
Ca recti 1 Herpes zoster 1
Ca coli 1 Nephrocolicae 1
Npl abdominis 1 Haemophilia 1
Non-Hodgkin lymphoma 1
Npl glandulae suprarenalis 1
Npl pancreatic 1
Npl ducti choledochi 1
Npl ovarii 1
TOTAL 22 16
*Difference between groups not statistically significant, Ca – carcinoma, Npl – neoplasm, SD – Standard Deviation
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Fig.1. Pain and pain impact ratings.
TABLE 2
PAIN MANAGEMENT AND ADVERSE EFFECTS OF PAIN THERAPY
Malignant pain (N=22) Non-malignant pain (N=16) p-value
N % N % n.s.*
Analgesics
Non-opioids 4 18 8 50 0,037
Opioids** 20 91 11 69
Weak opioids 19 82 9 56 n.s.
Strong opioids 6 27 2 1 n.s.
Combination therapy n.s.
Non-opioids + Weak opioids 1
Non-opioids + Strong opioids 1 0
Weak opioids + Strong opioids 4 0
TOTAL 6 27 3 19
Analgesics in continuous pain n.s.
»As needed« 6 46 4 57
Scheme 7 54 3 4
TOTAL 13 7
Analgesics in chronic pain n.s.
»As needed« 10 56 5
Scheme 8 44 3
TOTAL 18 8
Other pain treatment strategies n.s.
Radiation 1 0
Cold compress 0 1
Physical therapy 0 1
Massage 0 1
TOTAL 1 3
Adjuvant therapy n.s.
Benzodiazepine 5 3
Benzodiazepine + corticosteroid 1 0
Corticosteroids 2 3
Muscle relaxant 1 0
TOTAL 9 6
Adverse effects of pain therapy n.s.
Constipation 2 0
Sleepiness 0 2
Nausea 0 2
Sleepiness + nausea 1 0
*Difference between groups not statistically significant, **Alone and in combination
Statistics
Standard descriptive statistics were used to describe
the study population, their utilization of analgesics, pain
and pain impact scores, adverse effects and satisfaction
with the treatment received. The normality assumption
was tested using the Kolmogorov-Smirnov test. Means
and Standard Deviations (SD) were calculated for age,
and NRS. For categorical data proportions were calcu-
lated and analyzed using the c2. Continuous data were
statistically compared using the t-test for independent
samples. Statistical significance was set at p<0.05. All
tabulations and statistical analysis were done using Sta-
tistica for Windows, Version 5.5, StatSoft, Inc. (2000).
Results
Forty-one out of 167 hospitalized at the Department
of Medicine on the day of the study, 41 experienced pain
and 40 received analgesic therapy. One patient with occa-
sional headaches was not prescribed analgesics. Because
of differences in perception, attitudes and treatment of
malignant and non-malignant pain, we separately evalu-
ated the quality of pain management in these groups.
Two patients were excluded from the analysis, since it
was not possible to classify their pain as malignant or
non-malignant. Out of 38 patients with diagnosed clini-
cal condition, 22 (58%) were receiving analgesics for ma-
lignant pain, and 16 patients for non-malignant pain
(42%). Age and sex were comparable in both groups. Pa-
tients with malignant pain were experiencing more com-
mon chronic and continuous pain, as compared to pa-
tients with non-malignant pain (Table 1). Ratings of
worst and average pain were comparable for patients
with malignant and non-malignant pain, only current
pain was rated significantly higher in patients with non-
-malignant pain (Figure 1). Although the impact of pain
on general activities and sleep was rated higher in the
group of patients with malignant pain as compared to pa-
tients with non-malignant pain, it did not reach statisti-
cal significance. The impact of pain on mood was rated
similarly in both groups (Figure 1). One patient with ma-
lignant pain and 2 patients with non-malignant pain
were not able to comprehend the NRS.
Detailed data on pain management and adverse ef-
fects of pain therapy are shown in Table 2. Non-opioids
were significantly more prescribed for non-malignant
pain as compared to malignant pain, including acetami-
nophen, diclofenac, ketoprofen, piroxicam and aspirin.
Both weak (tramadol) and strong opioids (morphine sul-
phate and fentanyl), were more commonly prescribed in
patients with malignant pain, although not significantly.
Combination therapy was rather scarce in both groups,
prescribed in only 6 patients with malignant, and 3 pa-
tients with non-malignant pain. Overall, approximately
50% of all patients with continuous (10/20) and chronic
pain (15/26) were prescribed analgesics on »as needed«
basis, without significant difference between groups. Ot-
her pain management strategies were employed in only 1
patient with malignant pain and 3 patients with non-ma-
lignant pain. Approximately one third of patients in both
groups were prescribed adjuvant pain therapy. Four pa-
V. Erdelji} et al.: Pain Relief in Medical Patients, Coll. Antropol. 35 (2011) 2: 363–368
366
TABLE 3
WAITING TIME FOR ANALGESICS AND PATIENT’S SATISFACTION WITH ANALGESIA
Malignant pain Non-malignant pain p-value
N % N % n.s.**
Waiting time for analgesics*
10 min. 14 74 10 71
11–20 min. 1 5 0 0
21–30 min. 16 2 14
31–60 min. 0 0 0 0
>60 min. 0 0 1 7
never asked for pain medication 1 5 1 7
TOTAL 19 14
Patients’ satisfaction* n.s.**
Very satisfied 3 15 1 7
Satisfied 11 55 8 57
Moderately satisfied 4 20 2 14
Moderately unsatisfied 2 10 1 7
Unsatisfied 0 0 2 14
Very unsatisfied 0 0 0 0
TOTAL 20 14
*Missing data are due to patients not being able to remember their waiting times, or refusing to answer, ** Difference between groups
not statistically significant
tients in each group had complaints that could be attrib-
uted to analgesic therapy (tramadol). Adverse effects of
pain therapy were generally mild and recorded in 14% of
patients treated for malignant pain and 25% patients
treated for non-malignant pain. In all patients except one
they were recorded in patients receiving strong opioids.
Waiting time for analgesics after demand was similar
in both groups, with approximately 2/3 of patients in
both groups waiting <10 minutes on analgesic after de-
mand. Satisfaction level with the pain treatment was
high. Comparable rates of patients with malignant and
non-malignant pain were satisfied and very satisfied
with pain treatment (Table 3).
Discussion and Conclusion
There was no significant difference in pain manage-
ment between evaluated groups. Pain management was
unsatisfactory in both patients with malignant, as well
as in patients with non-malignant pain. Overall, satisfac-
tory pain relief was recorded in only 5/21 (24%) patients
with malignant pain and in 3/14 (21%) with non-malig-
nant pain, as indicated by worst pain scores 5 and aver-
age pain scores 3.
Although pain scores collected in similar studies were
even higher than recorded in our study10,11,28–30, we were
not satisfied with the fact that the average rating for
worst pain in both groups was above the threshold of
510–12. Five patients with malignant and 7 patients with
non-malignant pain rated their worst pain in the most
severe range of 7. The impact of pain on general activi-
ties, sleep and mood was rated higher in patients with
malignant pain. The clinical significance of recorded pain
scores in our study was illustrated by high interference
of pain with general activities, sleep and mood (all rated
>5, except for impact of pain on general activities in pa-
tients with non-malignant pain; Figure 1). Pain and pain
impact scores were to some extent higher in patients
with non-malignant pain, but only the difference in rat-
ing of current pain reached statistical significance. This
may be explained by differences in physicians’ and nur-
ses’ attitudes toward the clinical significance of non-ma-
lignant as compared to malignant pain, and according to
that, to underestimation and undertreatment of non-ma-
lignant pain.
Although more than half of the patients were experi-
encing continuous/chronic pain, approximately half of
them were receiving analgesics »as needed«. Without a
regular dosing scheme, a steady state blood level cannot
be reached in order for the drug to be continuously effec-
tive, and interruption of a regular scheme may cause a
reappearance of pain as blood levels of the analgesic
decline31. In one study by Owen at al.32 65% of patients
receiving pain medication on »as needed« basis stated
that they would wait until they had severe pain before
asking for analgesic.
The main therapy for both malignant and non-malig-
nant pain was a weak opioid (tramadol). The rate of pre-
scription of strong opioids was unsatisfactory, especially
in patients with malignant pain, as compared to other
studies17,33 with typical morphine prescription rate over
50%. Although not directly assessed by our study, we hy-
pothesize that the reason for under-prescription of strong
opioids for malignant pain is overestimation of the prob-
ability for addiction to prolonged use of narcotics, as this
has been recognized as one of the reasons for unsatisfac-
tory pain relief, as well as fear of adverse effects of ther-
apy with strong opioids1,18,34. Although all, except one, re-
corded adverse effects of pain therapy was attributed to
therapy with strong opioids, they were mild in all re-
corded cases. In one patient treated with tramadol, con-
stipation occurred as a suspected adverse effect.
Combination therapy, encouraged for more effective
analgesia and attenuation of opioid-induced adverse re-
actions, was clearly underprescribed in both groups. Al-
though it has been suggested that nurses often com-
pound the problem of physicians’ under-prescribing of
analgesics by under-administration of these drugs35,36,
the waiting times for analgesia recorded during our
study were short, which indirectly indicated good compli-
ance in administration of prescribed analgesics. Despite
high pain and pain impact scores as (more or less) objec-
tive parameters that indicate unsatisfactory pain man-
agement, patients’ satisfaction levels with pain relief
were high. However, high patient satisfaction rates have
not been established as an evidence for efficient pain
management, but may indicate patients’ tendency to
minimize pain and discomfort. There are many factors to
be taken into consideration in evaluation of patients’
pain behaviour. The role of physicians and nurses in pain
management is important and well documented, how-
ever the patients are often regarded merely as passive
care recipients37. Furthermore, it has been suggested
that the patients’ powerlessness in the hospital setting
would make them likely to deny the dissatisfaction with
hospital care38. Similar behavior was also noted during
our study and remains illustrated by 4 patients refusing
to assess their satisfaction with received pain treatment
and by the lack of filed reports on possible adverse effects
of pain therapy.
Nurses’ and physicians’ knowledge about pain man-
agement strategies, their attitudes toward pain and pain
relief, and the compliance in administration of prescribed
analgesics were not evaluated during this study. How-
ever, our results indirectly demonstrated flaws in physi-
cians’ knowledge of clinical assessment and treatment of
pain. Good compliance in administration of drugs is indi-
cated by low waiting times for analgesics upon request.
Data on efficacy of pain treatment in other Departments
are lacking, thus conclusions about differences in quality
of pain management among different medical specialities
at our hospital cannot be drawn.
We believe that lack of objective assessment of pain
and pain relief was the main barrier to satisfactory pain
treatment for medical patients. Regular measuring and
documentation of pain is essential for adequate pain
management39,40. It has been shown that pain frequently
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goes unrecognized by clinicians, when pain management
is based solely on their assessment41,42.
In conclusion, our study pointed to the need of estab-
lishing a local pain management quality improvement
program, since pain management remains inadequate if
based only on the clinical judgement and knowledge of
the prescribing physician. Further studies and pain man-
agement quality improvement programs focusing on dis-
regarded subgroups of patients (medical patients, geriat-
ric population, etc.) are clearly needed.
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LIJE^ENJE BOLI U INTERNISTI^KIH BOLESNIKA: DA LI SU KLINI^KA PROCJENA I ZNANJE
O PROPISIVANJU ANALGETIKA DOVOLJNI?
S A @ E T A K
Svrha ovog istra`ivanja bila je procijeniti kvalitetu lije~enja boli u hospitaliziranih internisti~kih bolesnika. Istra-
`ivanje je dizajnirano kao presje~no, a uklju~ilo je sve internisti~ke bolesnike hospitalizirane na Internoj klinici Klini-
~kog bolni~kog centra Zagreb koji su trpjeli bol. Od ukupno 167 hospitaliziranih bolesnika na Internoj klinici Klini~kog
bolni~kog centra Zagreb, 41 bolesnika koji su naveli da trpe bolove, 40 bolesnika primalo je analgetike. Dvadeset i dva
od 8 bolesnika lije~eno je zbog maligne boli, 16 bolesnika zbog nemaligne boli, dok se za 2 bolesnika uzrok boli nije
mogao svrstati u jednu od navedenih skupina. Primjerena kontrola boli zabilje`ena je u manje od 25% bolesnika u obje
istra`ivane skupine. Na{e je istra`ivanje ukazalo na nedovoljno propisivanje kombinirane analgetske terapije, nisku
stopu propisivanja jakih opioida te prevladavaju}e prepisivanje analgetika »prema potrebi«. Zaklju~no, lije~enje boli u
internisti~kih bolesnika ~esto je prepu{teno samo klini~koj procjeni i znanju lije~nika koji propisuje analgetik. Redovita
procjena boli, smjernice za lije~enje boli temeljene na dokazima, edukacija i redovite kontrole provo|enja uvedenih
mjera su pretpostavke za u~inkovito lije~enje boli, i trebaju biti primijenjeni u svih bolesnika koji trpe bol.
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